拉伸治疗产品市场－全球产业规模、份额、趋势、机会及预测（依产品类型、价格类别、通路、地区及竞争格局划分，2021-2031年）

全球拉伸治疗市场预计将从 2025 年的 15.8 亿美元成长到 2031 年的 21.7 亿美元，复合年增长率为 5.43%。

市场涵盖乳液、精油和乳霜等外用产品，旨在改善皮肤弹性，减少因怀孕或体重快速变化引起的妊娠纹。推动这一市场成长的主要因素是全球体重管理挑战日益严峻，以及消费者对产后美容护理的日益关注。庞大的消费族群对维持皮肤弹性的预防性产品有着稳定的需求。例如，根据世界肥胖联盟（WOF）发布的《2024年报告》，全球有超过10亿人肥胖，凸显了庞大的人口群体面临着皮肤弹性问题以及相应的补救措施需求。

儘管美容产业拥有巨大的成长潜力，但仍面临着许多障碍，其中之一是许多美容疗法缺乏经临床验证的疗效，导致消费者持怀疑态度。製造商往往难以提供与药品标准相媲美的严格医学证据来证实其宣传，这使得潜在买家犹豫不决。这种对疗效标准的信任缺失持续限制美容疗法的市场普及，并增加了寻求可靠疗效的终端使用者在决策流程中的复杂性。

市场驱动因素

体重快速波动是拉伸治疗市场的主要驱动因素，这主要归因于药物减重疗法的广泛应用。在短时间内体重显着下降的人，尤其是使用GLP-1受体促效剂的人，往往会出现皮肤弹性下降，从而导致拉伸的出现。这一趋势催生了一个特定的消费群体，他们需要能够恢復药物减肥后皮肤结构完整性的高效治疗方法。根据2024年5月凯撒家庭基金会（KFF）发布的健康追踪调查，约12%的成年人报告使用过GLP-1促效剂，而体重管理习惯的显着改变正在推动对皮肤弹性解决方案的需求成长。为此，各大公司正积极推广专为经历这些快速身体变化的人群设计的修復霜和精油。

同时，怀孕和产后护肤产品的需求日益增长，而临床疗效和安全性至关重要，这有力地支撑了市场。孕妇从怀孕初期就开始积极进行预防性皮肤护理，以尽量减少皮肤拉伸，并且更倾向于选择有医学验证的品牌而非普通化妆品。这种转变也体现在专注于治疗性护肤的公司的财务表现中。拜尔斯道夫于2024年2月发布的2023年度报告指出，其皮肤科部门（包括Aquaphor和Eucerin等品牌）的有机销售额成长了24%。同样，欧莱雅于2024年2月发布的2023年度报告显示，其皮肤科化妆品部门的销售额达到64亿欧元，凸显了消费者在这个人生关键阶段愿意投资于经科学验证的配方产品。

市场挑战

消费者普遍对局部用药的临床疗效持怀疑态度，严重阻碍了全球拉伸产品市场的成长。许多消费者认为，製造商的宣传与实际效果之间存在显着差距，尤其是在许多化妆品级产品缺乏严格的医学证据的情况下。这种不确定性使购买过程更加复杂，因为消费者不愿意购买那些无法保证达到与药物治疗同等皮肤科疗效的昂贵乳液、精油和乳霜。因此，这种信任缺失导致客户流失率上升，并在竞争激烈的市场环境中降低了品牌忠诚度。

这种持续的怀疑态度直接缩小了市场规模，因为人们越来越依赖医疗指导，而医疗指导对非处方预防措施的价值提出了质疑。对临床疗效数据的依赖往往对化妆品产业不利。例如，2024年，美国皮肤病学会发布了一项临床指南，指出使用橄榄油和可可脂等成分的常见家庭疗法在预防妊娠纹方面没有任何效果。这类数据加剧了消费者的犹豫，限制了外用产品的潜在市场，因为使用者可能会因为对疗效的怀疑而完全放弃治疗。

市场趋势

随着消费者，尤其是孕妇，越来越倾向于选择可追溯的植物来源替代品，洁净标示和有机配方的兴起正在从根本上改变产品开发。这种转变源于人们对减重计画和怀孕期间经皮吸收的潜在毒素日益关注，迫使製造商寻求第三方认证以支持其安全保证。统计数据也印证了这种对天然成分的需求。根据美国国家护肤基金会 (NSF) 2025 年 3 月发布的《个人护理产品购买习惯最新消费者资料》，74% 的消费者在选择个人保健产品时优先考虑有机成分。因此，各大品牌正在重新思考传统的拉伸霜配方，并去除邻苯二甲酸酯和对羟基苯甲酸酯。他们将植物来源成分的真实性确立为相对于传统药物基产品的关键竞争优势。

同时，经皮和奈米技术递送系统的创新正在解决产业长期以来面临的功效难题，提高活性成分向真皮层的渗透性。製造商不再局限于简单的保湿，而是利用封装技术将胶原蛋白生成胜肽和类视色素A直接输送到妊娠纹产生的受损皮肤层。这种向高效、经科学验证的护肤的转变，得益于业界对技术进步的大量投资。欧莱雅于2025年2月发布的2024年报告显示，该公司将在研发和创新方面投资超过13亿欧元。这项巨额资源投入标誌着产业策略从遮瑕转向治疗级修復，旨在缩小外用产品与侵入性临床手术之间的效果差距。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球拉伸治疗产品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（乳霜、身体乳、润肤露、精华液、按摩油）
  • 依价格类别（大众市场、高阶市场）
  • 按分销管道（超级市场/超级市场、药局/药局、专卖店、线上、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美拉伸产品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲拉伸产品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区拉伸治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲拉伸治疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲拉伸产品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球拉伸治疗产品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Clarins Group
• ET Browne Drug Co., Inc.
• Basq Skin Care, Inc.
• Weleda, Inc.
• Dermaclara, LLC
• Mama Mio Ltd
• L'Oreal SA
• Luxor Investments LLC
• Honasa Consumer Ltd.
• Himalaya Global Holdings Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Anti-Stretch Mark Products Market is projected to expand from USD 1.58 Billion in 2025 to USD 2.17 Billion by 2031, reflecting a compound annual growth rate of 5.43%. This market encompasses topical solutions like lotions, oils, and creams specifically developed to enhance skin elasticity and reduce the visibility of striae resulting from pregnancy or rapid weight changes. A primary factor fueling this growth is the increasing global prevalence of weight management challenges combined with a heightened consumer focus on postpartum aesthetic care. This broad demographic creates consistent demand for preventive skin resilience products. For instance, the World Obesity Federation reported in 2024 that over one billion individuals globally were living with obesity, underscoring the vast population vulnerable to skin stretching issues and the subsequent need for corrective measures.

Despite this growth potential, the industry faces a substantial hurdle related to the perceived absence of clinical efficacy in many cosmetic treatments, which breeds consumer skepticism. Manufacturers frequently encounter difficulties in validating their claims with rigorous medical evidence that matches pharmaceutical standards, causing hesitation among prospective buyers. This gap in trust concerning performance standards continues to limit wider market adoption and adds complexity to the decision-making process for end users who are looking for assured results.

Market Driver

The increasing incidence of rapid weight fluctuations acts as a pivotal driver for the anti-stretch mark products sector, largely driven by the widespread use of pharmaceutical weight-loss treatments. As individuals undergo significant body mass reduction over short periods, especially through the usage of GLP-1 receptor agonists, their skin often fails to maintain elasticity, resulting in striae formation. This trend has created a specific consumer group demanding high-performance topical remedies to restore skin structural integrity after medical weight management. According to the 'KFF Health Tracking Poll' from May 2024, roughly 12% of adults reported utilizing a GLP-1 agonist, indicating a major shift in weight control habits that stimulates downstream demand for skin resilience solutions. Consequently, companies are actively promoting corrective creams and oils specifically designed for those experiencing these intensive physical changes.

Concurrently, the market is strongly supported by the growing need for maternity and post-pregnancy skincare options where clinical efficacy and safety are essential. Expectant mothers are increasingly adopting preventive dermatological routines early in pregnancy to minimize skin stretching, favoring brands with robust medical credentials over standard cosmetic options. This shift is highlighted by the financial results of firms focused on therapeutic skincare; Beiersdorf's 'Annual Report 2023', released in February 2024, noted that their Derma business unit, featuring brands like Aquaphor and Eucerin, saw organic sales rise by 24%. Similarly, L'Oreal's '2023 Annual Report' from February 2024 showed their Dermatological Beauty Division achieved sales of 6.4 billion euros, demonstrating that consumers are willing to invest in scientifically backed formulations during pivotal life moments.

Market Challenge

Widespread consumer skepticism concerning the clinical effectiveness of topical formulations represents a major obstacle to the growth of the Global Anti-Stretch Mark Products Market. Many buyers feel there is a significant discrepancy between manufacturer marketing claims and visible outcomes, especially given the scarcity of rigorous medical proof for numerous cosmetic-grade products. This uncertainty makes the purchasing journey difficult, as consumers are hesitant to spend on expensive lotions, oils, or creams that cannot promise dermatological benefits similar to pharmaceutical treatments. As a result, this lack of trust elevates customer turnover and diminishes brand loyalty within a highly competitive market environment.

This lingering skepticism directly reduces market volume as individuals increasingly defer to medical guidance that questions the value of over-the-counter preventive measures. The reliance on clinical efficacy data often disadvantages the cosmetic industry. For example, in 2024, the American Academy of Dermatology Association released clinical guidelines stating that popular home remedies utilizing ingredients like olive oil or cocoa butter showed a 0 percent efficacy rate in preventing striae during pregnancy. Such data reinforces consumer hesitation, thereby restricting the potential market for topical solutions as users may choose to forego treatment altogether due to doubts regarding performance.

Market Trends

The rise of Clean Label and Organic Formulations is fundamentally reshaping product development as consumers, especially expectant mothers, increasingly avoid synthetic additives in favor of traceable, plant-based alternatives. This transition is fueled by intensified scrutiny regarding the transdermal absorption of potential toxins during weight loss regimens and pregnancy, forcing manufacturers to obtain third-party certifications to substantiate safety assurances. This demand for natural purity is backed by statistics; according to NSF's 'New Consumer Data on Personal Care Purchasing Habits' from March 2025, 74% of consumers prioritize organic ingredients in personal care items. Consequently, brands are reworking legacy stretch mark creams to eliminate phthalates and parabens, establishing botanical integrity as a key competitive advantage against traditional pharmaceutical options.

Simultaneously, innovation in Transdermal and Nanotech Delivery Systems is tackling the industry's historic efficacy challenges by improving the absorption of active compounds into the dermis. Manufacturers are advancing beyond simple hydration by employing encapsulation technologies to deliver collagen-stimulating peptides and retinoids directly to the damaged skin layers where striae form. This shift toward high-performance, scientifically validated skincare is demonstrated by significant industry spending on technical progress; L'Oreal's '2024 Annual Report', published in February 2025, reveals an investment of over 1.3 billion euros in Research & Innovation. Such considerable resource allocation highlights a strategic move from cosmetic concealers to therapeutic-grade reparative treatments, aimed at narrowing the performance disparity between topical applications and invasive clinical procedures.

Key Market Players

• Clarins Group
• E.T. Browne Drug Co., Inc.
• Basq Skin Care, Inc.
• Weleda, Inc.
• Dermaclara, LLC
• Mama Mio Ltd
• L'Oreal S.A.
• Luxor Investments LLC
• Honasa Consumer Ltd.
• Himalaya Global Holdings Ltd.

Report Scope

In this report, the Global Anti-Stretch Mark Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-Stretch Mark Products Market, By Product Type

• Creams
• Body Butter
• Lotions
• Serum
• Massage Oil

Anti-Stretch Mark Products Market, By Price Category

• Mass
• Premium

Anti-Stretch Mark Products Market, By Distribution Channel

• Hypermarkets/Supermarkets
• Pharmacy/Drug Stores
• Specialty Stores
• Online
• Others

Anti-Stretch Mark Products Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-Stretch Mark Products Market.

Available Customizations:

Global Anti-Stretch Mark Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anti-Stretch Mark Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Creams, Body Butter, Lotions, Serum, Massage Oil)
  • 5.2.2. By Price Category (Mass, Premium)
  • 5.2.3. By Distribution Channel (Hypermarkets/Supermarkets, Pharmacy/Drug Stores, Specialty Stores, Online, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Anti-Stretch Mark Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Price Category
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anti-Stretch Mark Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Price Category
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Anti-Stretch Mark Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Price Category
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Anti-Stretch Mark Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Price Category
      • 6.3.3.2.3. By Distribution Channel

7. Europe Anti-Stretch Mark Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Price Category
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anti-Stretch Mark Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Price Category
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Anti-Stretch Mark Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Price Category
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Anti-Stretch Mark Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Price Category
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Anti-Stretch Mark Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Price Category
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Anti-Stretch Mark Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Price Category
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Anti-Stretch Mark Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Price Category
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anti-Stretch Mark Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Price Category
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Anti-Stretch Mark Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Price Category
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Anti-Stretch Mark Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Price Category
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Anti-Stretch Mark Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Price Category
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Anti-Stretch Mark Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Price Category
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Anti-Stretch Mark Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Price Category
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anti-Stretch Mark Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Price Category
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Anti-Stretch Mark Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Price Category
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Anti-Stretch Mark Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Price Category
      • 9.3.3.2.3. By Distribution Channel

10. South America Anti-Stretch Mark Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Price Category
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anti-Stretch Mark Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Price Category
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Anti-Stretch Mark Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Price Category
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Anti-Stretch Mark Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Price Category
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anti-Stretch Mark Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Clarins Group
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. E.T. Browne Drug Co., Inc.
• 15.3. Basq Skin Care, Inc.
• 15.4. Weleda, Inc.
• 15.5. Dermaclara, LLC
• 15.6. Mama Mio Ltd
• 15.7. L'Oreal S.A.
• 15.8. Luxor Investments LLC
• 15.9. Honasa Consumer Ltd.
• 15.10. Himalaya Global Holdings Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer